Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dipentamethylenethiuram disulfide is a small molecule used primarily as an accelerator and vulcanizing agent in the rubber industry. It is also a standardized chemical allergen found in latex gloves and other rubber products commonly encountered in homes and offices. Medically, it is used as a component of the Thiuram Mix for epicutaneous patch testing (T.R.U.E. TEST), which aids in diagnosing allergic contact dermatitis by identifying sensitivity to specific allergens. Its physiologic effect involves increased histamine release and cell-mediated immunity[1][2][3][4]. The T.R.U.E. TEST containing this compound was approved by the FDA in 1994 for use as an aid in diagnosing allergic contact dermatitis[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on dipentamethylenethiuram disulfide.